CD274 and breast carcinoma: Through in-depth mechanistic studies, we revealed that NDUFAF6 affects immune infiltration and tumor growth in BC by inhibiting the NRF2 signaling pathway, thereby promoting PD-L1 expression in breast cancer cells (Fig. 8).